{"id":2088,"date":"2023-04-18T06:37:01","date_gmt":"2023-04-18T06:37:01","guid":{"rendered":"https:\/\/ceowebltd.com\/blog\/?p=2088"},"modified":"2023-04-18T06:37:01","modified_gmt":"2023-04-18T06:37:01","slug":"from-bench-to-bedside-the-future-of-clinical-oncology-next-generation-sequencing-market-by-2029","status":"publish","type":"post","link":"https:\/\/ceowebltd.com\/blog\/from-bench-to-bedside-the-future-of-clinical-oncology-next-generation-sequencing-market-by-2029\/","title":{"rendered":"From Bench to Bedside: The Future of Clinical Oncology Next-Generation Sequencing Market by 2029"},"content":{"rendered":"

Clinical Oncology Next-Generation Sequencing Market\u00a0Overview:<\/strong><\/p>\n

The “Clinical Oncology Next-Generation Sequencing Market\u00a0Analysis<\/strong>” is an in-depth look at the\u00a0Clinical Oncology Next-Generation Sequencing Market\u00a0<\/u><\/a><\/strong>with a focus on global market trends and analysis. This study seeks to provide an overview of the\u00a0Clinical Oncology Next-Generation Sequencing Market\u00a0\u00a0industry as well as detailed market segmentation by segment and geography. The\u00a0Clinical Oncology Next-Generation Sequencing Market\u00a0\u00a0is expected to expand rapidly over the forecast period. The research contains critical information on the market positions of the top\u00a0Clinical Oncology Next-Generation Sequencing Market\u00a0firms, as well as significant industry trends and opportunities.<\/p>\n

Clinical Oncology Next-Generation Sequencing Market<\/strong>\u00a0size was valued at US $ 7.86 Bn.in 2022 and the total revenue is expected to grow at 20.7% through 2022 to 2029, reaching nearly US$ 2.93 Bn.<\/p>\n

Sample Request For\u00a0Clinical Oncology Next-Generation Sequencing Market\u00a0:\u00a0https:\/\/www.maximizemarketresearch.com\/request-sample\/100383<\/a>\u00a0<\/strong><\/p>\n

Market Scope:<\/strong><\/p>\n

To validate the market size and estimate the market size by different segments, top-down and bottom-up methodologies are utilized. The research’s market estimates are based on the sale price (excluding any discounts provided by the manufacturer, distributor, wholesaler, or traders). Weights applied to each section based on usage rate and average sale price are used to determine percentage splits, market shares, and segment breakdowns. The percentage adoption or usage of the provided market Size in the relevant area or nation is used to determine the country-wise splits of the overall market and its sub-segments.<\/p>\n

Inquiry For Report :\u00a0https:\/\/www.maximizemarketresearch.com\/request-sample\/100383<\/a>\u00a0<\/strong><\/p>\n

Clinical Oncology Next-Generation Sequencing Market\u00a0Segmentation:<\/strong><\/p>\n

With a market share of more than 72% in 2020, the targeted sequencing and resequencing segment has seen tremendous growth in terms of technology. The cost, time, and amount of data analysed during tumour sample sequencing typically decrease with the use of targeted cancer sequencing panels. Furthermore, the treatment efficacy of targeted panels is enhanced by the ability to detect malignant tumours. According to a study published in JCO Precision Oncology, 2020, NGS panels are clinically effective in 64% of cancer cases.Sequencing, which accounted for more than 54% of total revenue, was the most lucrative process category according to process. The workflow’s critical step of sequencing necessitates the usage of specialised platforms. The growth of the segment is further supported by an increase in cancer sequencing programmes.<\/p>\n

 <\/p>\n

Clinical Oncology Next-Generation Sequencing Market\u00a0Key Players:<\/strong><\/p>\n

Primary and secondary research is used to discover industry titans, while primary and secondary research is utilized to assess market revenue. The core research included in-depth interviews with a variety of thought leaders and industry experts, including experienced front-line personnel, CEOs, and marketing specialists. Secondary research comprised an examination of well-known manufacturers’ annual and financial reports. Secondary data is utilized to calculate percentage splits, market shares, growth rates, and global market breakdowns, which are then cross-checked against primary data. The following are a few companies working in the\u00a0Clinical Oncology Next-Generation Sequencing Market\u00a0\u00a0industry.<\/p>\n